Doctor profile · Federal record
Dr. FAHEEM ABBASI, MD
Pulmonary Disease Physician (CMS: CRITICAL CARE (INTENSIVISTS)) · Internal Medicine Physician · INDIANAPOLIS, IN
- NPI 1043486343
- Accepts Medicare
- 35 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1402 E COUNTY LINE RD, SUITE 2400
INDIANAPOLIS, IN 462270963
(317) 887-7000
fax (317) 355-8734 - Mailing address
-
6626 E 75TH ST, SUITE 500
INDIANAPOLIS, IN 462502805
Credentials & registration
- NPI registered
- May 2008 — 18 yrs on file
- Profile last updated
- November 27, 2023
- Year of graduation
- 1991 — 35 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- Indiana #01051717A
- Medicaid
- IN #200294680
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1043486343. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,494
Distinct HCPCS
10
Medicare allowed
$123,976
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 376 | 309 | $82 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 159 | 119 | $117 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 141 | 66 | $110 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 130 | 64 | $74 | |
G0400 |
Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels | 92 | 91 | $39 | |
94060 |
Test to measure expiratory airflow and volume changes before and after medication administration | 53 | 53 | $10 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 52 | 52 | $103 | |
94726 |
Test to determine lung volumes using sensors | 51 | 51 | $11 | |
94729 |
Test to examine how well the lungs exchange gases | 51 | 51 | $8 | |
99291 |
Critical care, first 30-74 minutes | 49 | 28 | $194 |
In context: peer comparison
Among 21 peers in this city , average services per provider: 66. This provider delivers 23× the peer median.Open Payments
Industry payments received
All-time total
$911
Transactions
36
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 4 | $140.86 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $90.87 | |
| AstraZeneca Pharmaceuticals LP | 4 | $62.75 | |
| Janssen Pharmaceuticals, Inc | 3 | $58.39 | |
| HARMONY BIOSCIENCES LLC | 2 | $54.36 | |
| Avadel CNS Pharmaceuticals, LLC | 2 | $54.15 | |
| Mylan Specialty L.P. | 3 | $51.76 | |
| Merck Sharp & Dohme LLC | 2 | $49.90 | |
| Electromed, Inc. | 3 | $46.21 | |
| GlaxoSmithKline, LLC. | 3 | $45.88 | |
| PFIZER INC. | 2 | $37.01 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $28.62 | |
| Mallinckrodt Hospital Products Inc. | 1 | $27.25 | |
| Inari Medical, Inc. | 1 | $27.15 | |
| Axsome Therapeutics, Inc. | 1 | $24.48 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,281
Patients
660
Total drug cost
$794,949
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 368 | 122 | $13,142 |
| Prednisone | Generic | 365 | 154 | $1,008 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 343 | 71 | $336,122 |
| Doxycycline Hyclate | Generic | 192 | 96 | $1,836 |
| Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) | Brand | 142 | 30 | $96,387 |
| Montelukast Sodium | Generic | 138 | 43 | $2,243 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 106 | 27 | $57,560 |
| Dextroamphetamine-Amphetamine (Dextroamphetamine/Amphetamine) | Brand | 92 | 18 | $2,577 |
| Zolpidem Tartrate | Generic | 92 | 15 | $1,100 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 85 | 25 | $73,794 |